The impact of treatment modality on quality of life in glaucoma patients: findings from a clinical survey study in Augusta, GA
Open Access
- 29 December 2025
- journal article
- research article
- Published by Springer Nature in International Ophthalmology
- Vol. 46 (1) , 55
Abstract
Purpose: This study evaluates the impact of medical versus combined medical and surgical glaucoma treatments on patients’ quality of life (QoL). While both approaches reduce intraocular pressure, research shows mixed effects on QoL. Given updated clinical guidelines and the gap in QoL-focused glaucoma management, this study applies validated QoL measures to assess treatment effects and inform patient-centered care. Methods: From June to October 2023, 180 patients at Augusta University Eye Care Center completed the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25) and Glaucoma Profile Instrument (GPI) surveys. Chart reviews provided demographic and clinical data, including glaucoma status and treatment. QoL scores were calculated using validated algorithms. Associations between clinical variables and QoL outcomes were analyzed using ANOVA and t-tests in R 4.4.1. Results: Among 180 patients, 103 had glaucoma or were suspects. 64% of glaucoma patients received medical treatment only, and 34% received combined medical and surgical treatment. VFQ-25 scores differed significantly by race ( p = 0.0489), severity ( p = 0.0001), and age ( p = 0.0459), but not by gender, glaucoma status, or treatment. Severe glaucoma patients had the lowest QoL. Severity strongly impacted GPI scores ( p = 0.0092) and multiple VFQ-25 domains. Differences by treatment modality were observed only in the driving subscale ( p = 0.0378). No significant differences were observed in overall QoL scores between treatment groups. Conclusion: No significant vision-related QoL differences were found between treatment groups. Most patients were medically managed, possibly reflecting limited QoL benefit from surgery. QoL correlated more with disease severity than treatment modality or demographics. These findings highlight a disconnect between current treatment strategies and patient-perceived outcomes, underscoring the need for innovative strategies to improve QoL in glaucoma care.Keywords
This publication has 43 references indexed in Scilit:
- Quality of life in glaucomaGraefe's Archive for Clinical and Experimental Ophthalmology, 2023
- Vision-Related Quality of Life Among Healthy, Preperimetric Glaucoma, and Perimetric Glaucoma PatientsAmerican Journal of Ophthalmology, 2022
- Race and Ethnicity Differences in Disease Severity and Visual Field Progression Among Glaucoma PatientsAmerican Journal of Ophthalmology, 2022
- The Burden of Caring for and Treating Glaucoma: The Patient PerspectiveOphthalmology Glaucoma, 2022
- Quality of Life in Primary Open-Angle Glaucoma and Cataract: An Analysis of VFQ-25 and OSDI From the iStent inject® Pivotal TrialAmerican Journal of Ophthalmology, 2021
- Quality of Life in Glaucoma: A Review of the LiteratureAdvances in Therapy, 2016
- Ocular Surface Disease and Quality of Life in Patients With GlaucomaAmerican Journal of Ophthalmology, 2012
- Results of the European Glaucoma Prevention StudyOphthalmology, 2005
- The Ocular Hypertension Treatment StudyArchives of Ophthalmology (1950), 2002
- Development of the 25-list-item National Eye Institute Visual Function QuestionnaireArchives of Ophthalmology (1950), 2001